Erratum: Integrated genomic characterization of endometrial carcinoma (Nature (2013) 497 (67-73) Doi:10.1038/nature12113);Integrated genomic characterization of endometrial carcinoma

Nature

Volumn 497, Issue 7447, 2013, Pages 67-73

  Getz, Gad ^a   Gabriel, Stacey B ^a   Cibulskis, Kristian ^a   Lander, Eric ^a   Sivachenko, Andrey ^a   Sougnez, Carrie ^a   Lawrence, Mike ^a   Kandoth, Cyriac ^b   Dooling, David ^b   Fulton, Robert ^b   Fulton, Lucinda ^b   Kalicki Veizer, Joelle ^b   McLellan, Michael D ^b   O'Laughlin, Michelle ^b   Schmidt, Heather ^b   Wilson, Richard K ^b   Ye, Kai ^b   Li, Ding ^b   Ally, Adrian ^c   Balasundaram, Miruna ^c   Birol, Inanc ^c   Butterfield, Yaron S N ^c   Carlsen, Rebecca ^c   Carter, Candace ^c   Chu, Andy ^c   Chuah, Eric ^c   Chun, Hye Jung E ^c   Dhalla, Noreen ^c   Guin, Ranabir ^c   Hirst, Carrie ^c   Holt, Robert A ^c   Jones, Steven J M ^c   Lee, Darlene ^c   Li, Haiyan I ^c   Marra, Marco A ^c   Mayo, Michael ^c   Moore, Richard A ^c   Mungall, Andrew J ^c   Plettner, Patrick ^c   Schein, Jacqueline E ^c   Sipahimalani, Payal ^c   Tam, Angela ^c   Varhol, Richard J ^c   Gordon Robertson, A ^c,c   Cherniack, Andrew D ^a   Pashtan, Itai ^a,d   Saksena, Gordon ^a   Onofrio, Robert C ^a   Schumacher, Steven E ^a   Tabak, Barbara ^a   Carter, Scott L ^a   Hernandez, Bryan ^a   Gentry, Jeff ^a   Salvesen, Helga B ^a,e,f   Ardlie, Kristin ^a   Winckler, Wendy ^a   Beroukhim, Rameen ^a,d,m   Meyerson, Matthew ^a,d   Hadjipanayis, Angela ^g   Lee, Semin ^h   Mahadeshwar, Harshad S ^a   Park, Peter ^h,j   Protopopov, Alexei ⁱ   Ren, Xiaojia ^g   Seth, Sahil ⁱ   Song, Xingzhi ⁱ   Tang, Jiabin ⁱ   Xi, Ruibin ^h   Yang, Lixing ^h   Dong, Zeng ⁱ   Kucherlapati, Raju ^g   Chin, Lynda ^a,i   Zhang, Jianhua ^a,i   Todd Auman, J ^k,l   Balu, Saianand ^l   Bodenheimer, Tom ^l   Buda, Elizabeth ^l   Neil Hayes, D ^l,m   Hoyle, Alan P ^l   Jefferys, Stuart R ^l   Jones, Corbin D ^l   Meng, Shaowu ^l   Mieczkowski, Piotr A ^m   Mose, Lisle E ^l   Parker, Joel S ^l   Perou, Charles M ^l,m   Roach, Jeff ^l   Yan, Shi ^l   Simons, Janae V ^l   Soloway, Mathew G ^l   Tan, Donghui ^l   Topal, Michael D ^l,m   Waring, Scot ^l   Wu, Junyuan ^l   Hoadley, Katherine A ^l,m   Baylin, Stephen B ⁿ   Bootwalla, Moiz S ^o   Lai, Phillip H ^o   Triche, Timothy J ^o   Van Den Berg, David J ^o   Weisenberger, Daniel J ^o   Laird, Peter W ^o   Shen, Hui ^a,i,o   Cho, Juok ^a   Dicara, Daniel ^a   Frazer, Scott ^a   Heiman, David ^a   Jing, Rui ^a   Lin, Pei ^a   Mallard, Will ^a   Stojanov, Petar ^a   Voet, Doug ^a   Zhang, Hailei ^a   Zou, Lihua ^a   Noble, Michael ^a   Reynolds, Sheila M ^p   Shmulevich, Ilya ^p   Arman Aksoy, B ^q   Antipin, Yevgeniy ^q   Ciriello, Giovanni ^q   Dresdner, Gideon ^q   Gao, Jianjiong ^q   Gross, Benjamin ^q   Jacobsen, Anders ^q   Ladanyi, Marc ^q   Reva, Boris ^q   Sander, Chris ^q   Sinha, Rileen ^q   Onur Sumer, S ^q   Taylor, Barry S ^r   Cerami, Ethan ^q   Weinhold, Nils ^q   Schultz, Nikolaus ^q   Shen, Ronglai ^q   Benz, Stephen ^s   Goldstein, Ted ^s   Haussler, David ^s   Ng, Sam ^s   Szeto, Christopher ^s   Stuart, Joshua ^s   Benz, Christopher C ^t   Yau, Christina ^t   Zhang, Wei ⁱ   Annala, Matti ^i,u   Broom, Bradley M ⁱ   Casasent, Tod D ⁱ   Ju, Zhenlin ⁱ   Liang, Han ⁱ   Liu, Guoyan ⁱ   Lu, Yiling ⁱ   Unruh, Anna K ⁱ   Wakefield, Chris ⁱ   Weinstein, John N ⁱ   Zhang, Nianxiang ⁱ   Liu, Yuexin ⁱ   Broaddus, Russell ⁱ   Akbani, Rehan ⁱ   Mills, Gordon B ⁱ   Adams, Christopher ^v   Barr, Thomas ^v   Black, Aaron D ^v   Bowen, Jay ^v   Deardurff, John ^v   Frick, Jessica ^v   Gastier Foster, Julie M ^v,w   Grossman, Thomas ^v   Harper, Hollie A ^v   Hart Kothari, Melissa ^v   Helsel, Carmen ^v   Hobensack, Aaron ^v   Kuck, Harkness ^v   Kneile, Kelley ^v   Leraas, Kristen M ^v   Lichtenberg, Tara M ^v   McAllister, Cynthia ^v   Pyatt, Robert E ^v   Ramirez, Nilsa C ^v,w   Tabler, Teresa R ^v   Vanhoose, Nathan ^v   White, Peter ^v   Wise, Lisa ^v   Zmuda, Erik ^v   Barnabas, Nandita ^x   Berry Green, Charlenia ^x   Blanc, Victoria ^x   Boice, Lori ^l   Button, Michael ^x   Farkas, Adam ^x   Green, Alex ^x   MacKenzie, Jean ^x   Nicholson, Dana ^x   Kalloger, Steve E ^c,y   Blake Gilks, C ^c,y   Karlan, Beth Y ^z   Lester, Jenny ^z   Orsulic, Sandra ^z   Borowsky, Mark ^aa   Cadungog, Mark ^aa   Czerwinski, Christine ^aa   Huelsenbeck Dill, Lori ^aa   Iacocca, Mary ^aa   Petrelli, Nicholas ^aa   Rabeno, Brenda ^aa   Witkin, Gary ^aa   Nemirovich Danchenko, Elena ^ab   Potapova, Olga ^ab   Rotin, Daniil ^ab   Berchuck, Andrew ^ac   Birrer, Michael ^ad   Disaia, Phillip ^ae   Monovich, Laura ^v   Curley, Erin ^af   Gardner, Johanna ^af   Mallery, David ^af   Penny, Robert ^af   Dowdy, Sean C ^ag   Winterhoff, Boris ^ag   Dao, Linda ^ag   Gostout, Bobbie ^ag   Meuter, Alexandra ^ag   Teoman, Attila ^ag   Dao, Fanny ^q   Olvera, Narciso ^q   Bogomolniy, Faina ^q   Garg, Karuna ^q   Soslow, Robert A ^q   Abramov, Mikhail ^ah   Bartlett, John M S ^ai   Kodeeswaran, Sugy ^ai   Parfitt, Jeremy ^aj   Moiseenko, Fedor ^ak   Clarke, Blaise A ^al   Goodman, Marc T ^z,am   Carney, Michael E ^am   Matsuno, Rayna K ^am   Fisher, Jennifer ^l   Huang, Mei ^l   Kimryn Rathmell, W ^l   Thorne, Leigh ^l   Van Le, Linda ^l   Dhir, Rajiv ^an   Edwards, Robert ^an   Elishaev, Esther ^an   Zorn, Kristin ^an   Goodfellow, Paul J ^b,i,w   Mutch, David ^b   Kahn, Ari B ^ao   Bell, Daphne W ^ap   Pollock, Pamela M ^aq   Wang, Chen ^ag   Wheeler, David ^ar   Shinbrot, Eve ^ar   Ding, Li ^b   Mardis, Elaine R ^b   Ayala, Brenda ^ao   Chu, Anna L ^ao   Jensen, Mark A ^ao   Kothiyal, Prachi ^ao   Pihl, Todd D ^ao   Pontius, Joan ^ao   Pot, David A ^ao   Snyder, Eric E ^ao   Srinivasan, Deepak ^ao   Mills Shaw, Kenna R ^as   Sheth, Margi ^as   Davidsen, Tanja ^as   Eley, Greg ^at   Ferguson, Martin L ^au   Yang, Liming ^as   Guyer, Mark S ^ap   Ozenberger, Bradley A ^ap   Sofia, Heidi J ^ap   Levine, Douglas A ^q   more..

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF BERGEN   (Norway)

^g HARVARD MEDICAL SCHOOL   (United States)

^h Harvard Medical School Center for Biomedical Informatics   (United States)

ⁱ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^j BOSTON CHILDREN S HOSPITAL   (United States)

^k University of North Carolina   (United States)

^l UNIVERSITY OF NORTH CAROLINA   (United States)

^m UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁿ JOHNS HOPKINS UNIVERSITY   (United States)

^o UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^p INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^q MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^r UNIVERSITY OF CALIFORNIA   (United States)

^s University of California Santa Cruz   (United States)

^t BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^u TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^v THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^w OHIO STATE UNIVERSITY   (United States)

^x Asterand   (United States)

^y UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^z CEDARS SINAI MEDICAL CENTER   (United States)

^aa HELEN F GRAHAM CANCER CENTER   (United States)

^ab Cedars Sinai Medical Center ^*  (United States)

^ac DUKE UNIVERSITY MEDICAL CENTER   (United States)

^ad MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^ae UNIVERSITY OF CALIFORNIA   (United States)

^af International Genomics Consortium   (United States)

^ag MAYO CLINIC   (United States)

^ah N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^ai ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^aj LONDON HEALTH SCIENCES CENTRE   (Canada)

^ak ST PETERSBURG ACADEMIC UNIVERSITY   (Russian Federation)

^al UNIVERSITY HEALTH NETWORK   (Canada)

^am UNIVERSITY OF HAWAII   (United States)

^an UNIVERSITY OF PITTSBURGH   (United States)

^ao GENERAL DYNAMICS   (United States)

^ap NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^aq QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^ar BAYLOR COLLEGE OF MEDICINE   (United States)

^as NATIONAL CANCER INSTITUTE   (United States)

^at Scimentis   (United States)

^au MLF Consulting   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGESTERONE RECEPTOR; PROTEIN P53;

CANCER; CHROMOSOME; DISEASE TREATMENT; GENOMICS; HORMONE; METHYLATION; MUTATION; TUMOR; WOMENS HEALTH; GENE EXPRESSION;

ARTICLE; CANCER GENETICS; CELL METABOLISM; CHROMATIN; CHROMOSOME ABERRATION; CLINICAL TRIAL (TOPIC); COPY NUMBER VARIATION; DNA METHYLATION; ENDOMETRIUM CARCINOMA; EXOME; FEMALE; FOLLOW UP; GENE MUTATION; GENOMICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MUTATION RATE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEOMICS; RNA SEQUENCE; SEQUENCE ANALYSIS; TRANSCRIPTOMICS; ARID1A GENE; ARID5B GENE; BASAL LIKE BREAST CANCER; CANCER GRADING; CHROMATIN ASSEMBLY AND DISASSEMBLY; CTNNB1 GENE; DNA MICROARRAY; DNA SEQUENCE; GENE; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE K RAS; OVARY CARCINOMA; PIK3CA GENE; PTEN GENE; SOMATIC HYPERMUTATION; STRUCTURAL CHROMOSOME ABERRATION; UTERUS TUMOR;

EID: 84877254190     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12325     Document Type: Erratum

References (40)

1. Siegel, R., Naishadham, D.&Jemal, A. Cancer statistics, 2013. CACancer J. Clin.63, 11-30 (2013).
2. Fleming, G. F. et al. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J. Clin. Oncol. 22, 2159-2166 (2004).
3. Sutton, G. et al. Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study. Gynecol. Oncol. 97, 755-763 (2005).
4. Lax, S. F. & Kurman, R. J. A dualistic model for endometrial carcinogenesis based onimmunohistochemical andmolecular genetic analyses. Verh. Dtsch. Ges. Pathol. 81, 228-232 (1997).
5. Cheung, L. W. et al. High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanismfor regulation of PTEN protein stability. Cancer Discov. 1, 170-185 (2011).
6. Levine, R. L. et al. PTENmutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res. 58, 3254-3258 (1998).
7. McConechy, M. K. et al. Use of mutation profiles to refine the classification of endometrial carcinomas. J. Pathol. 228, 20-30 (2012).
8. Byron, S. A. et al.FGFR2pointmutations in466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features. PLoS ONE 7, e30801 (2012).
9. Urick, M. E. et al. PIK3R1 (p85a) is somatically mutated at high frequency in primary endometrial cancer. Cancer Res. 71, 4061-4067 (2011).
10. Zighelboim, I. et al. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type. J. Clin. Oncol. 25, 2042-2048 (2007).
11. Kuhn, E. et al. Identification of molecular pathway aberrations in uterine serous carcinomaby genome-wide analyses. J.Natl. Cancer Inst. 104, 1503-1513(2012).
12. Le Gallo, M. et al. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nature Genet. 44, 1310-1315 (2012).
13. Salvesen, H. B. et al. Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Proc. Natl Acad. Sci. USA 106, 4834-4839 (2009).
14. Cowin, P. A. et al. LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin. Cancer Res. 72, 4060-4073 (2012).
15. The Cancer Genome Atlas Network.Comprehensivemolecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012).
16. Govindan, R. et al. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 150, 1121-1134 (2012).
17. Pleasance, E. D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191-196 (2010).
18. Palles, C. et al. Germline mutations affecting the proofreading domains of POLE andPOLD1 predispose to colorectal adenomasandcarcinomas.NatureGenet. 45, 136-144 (2013).
19. Bartosch, C. et al. Endometrial carcinomas: a reviewemphasizing overlapping and distinctive morphological and immunohistochemical features. Adv. Anat. Pathol. 18, 415-437 (2011).
20. Toyota, M. et al. CpG island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA 96, 8681-8686 (1999).
21. Hinoue, T. et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res. 22, 271-282 (2012).
22. Noushmehr, H. et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17, 510-522 (2010).
23. Shen, R., Olshen, A. B.&Ladanyi, M. Integrative clustering ofmultiple genomicdata types using a joint latent variablemodel with application to breast and lung cancer subtype analysis. Bioinformatics 25, 2906-2912 (2009).
24. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D. & Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336 (1990).
25. Ciriello, G., Cerami, E., Sander, C.&Schultz, N.Mutual exclusivity analysis identifies oncogenic network modules. Genome Res. 22, 398-406 (2012).
26. Li, J., Mizukami, Y., Zhang, X., Jo, W. S. & Chung, D. C. Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3b. Gastroenterology 128, 1907-1918 (2005).
27. Zorn, A. M. et al. Regulation of Wnt signaling by Sox proteins: XSox17 a/b and XSox3 physically interact with b-catenin. Mol. Cell 4, 487-498 (1999).
28. Sinner, D. et al. Sox17andSox4 differentially regulateb-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol. Cell. Biol. 27, 7802-7815 (2007).
29. Pollock, P. M. et al. Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene 26, 7158-7162 (2007).
30. Fleming, G. F. et al. Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol. 116, 15-20 (2010).
31. Vaske, C. J. et al. Inference of patient-specific pathway activities from multidimensional cancer genomics data using PARADIGM. Bioinformatics 26, i237-i245 (2010).
32. The Cancer Genome Atlas Network. Comprehensivemolecular portraits of human breast tumours. Nature 490, 61-70 (2012).
33. The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615 (2011).
34. Clarke, B. A. & Gilks, C. B. Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type. J. Clin. Pathol. 63, 410-415 (2010).
35. Yemelyanova, A. et al. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases. Am. J. Surg. Pathol. 33, 1504-1514 (2009).
36. Gilks,C.B., Oliva, E.&Soslow, R. A.Poor inter-observer reproducibility inthediagnosis of high-grade endometrial carcinoma. Am. J. Surg. Pathol. 91, 248A (2012).
37. Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).
38. Gaujoux, R.&Seoighe, C. A flexible R package for nonnegative matrix factorization. BMC Bioinformatics 11, 367 (2010).
39. Houseman, E. A. et al. Model-based clustering of DNA methylation array data: a recursive-partitioning algorithmfor high-dimensional data arising as a mixture of beta distributions. BMC Bioinformatics 9, 365 (2008).
40. Brunet, J. P., Tamayo, P., Golub, T. R. & Mesirov, J. P. Metagenes and molecular pattern discovery using matrix factorization. Proc. Natl Acad. Sci. USA 101, 4164-4169 (2004).